Top 10 Pharmaceutical Stocks to Watch in 2025, Let us have a look.

Eli Lilly (LLY)

With groundbreaking therapies like Mounjaro for diabetes and donanemab for Alzheimer’s, Eli Lilly continues to dominate the sector.

Novo Nordisk (NVO)

This company has established itself as a leader in diabetes care and obesity treatments.

Regeneron Pharmaceuticals (REGN) 

Known for its strong portfolio in ophthalmology and immunology, Regeneron has ongoing success with Eylea.

AstraZeneca (AZN)

AstraZeneca (AZN)

AstraZeneca remains a leader in oncology with drugs like Tagrisso and Imfinzi while expanding into cardiovascular and rare diseases.

Vertex Pharmaceuticals (VRTX) 

Renowned for its cystic fibrosis treatments, Vertex is diversifying into other areas such as sickle cell disease and pain management 

Biogen (BIIB)

Biogen (BIIB)

With the FDA approval of Leqembi (lecanemab) for Alzheimer’s and a focus on neurology, Biogen remains a key player to monitor.

Pfizer (PFE)

Despite a drop in COVID-related revenues, Pfizer's pipeline includes oncology and rare disease therapies that could bolster growth.

Gilead Sciences (GILD)

Gilead continues to expand in oncology with Trodelvy while maintaining its leadership in HIV treatments.

Moderna (MRNA)

As mRNA technology evolves, Moderna is advancing its portfolio with vaccines for cancer and other infectious diseases.

Alkermes (ALKS)

This mid-cap company has strong potential with its neurological and psychiatric drugs, including combination therapies in development.